BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 9874273)

  • 1. Novel tools for production and purification of recombinant adenoassociated virus vectors.
    Grimm D; Kern A; Rittner K; Kleinschmidt JA
    Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing recombinant adeno-associated virus production.
    Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
    Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
    Collaco RF; Cao X; Trempe JP
    Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences.
    Shi S; Mercer SA; Dilley R; Trippel SB
    Virol J; 2009 Jan; 6():3. PubMed ID: 19128486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
    Shiau AL; Liu PS; Wu CL
    J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
    Fan PD; Dong JY
    Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for highly regulated rep gene expression in adeno-associated virus vector production.
    Li J; Samulski RJ; Xiao X
    J Virol; 1997 Jul; 71(7):5236-43. PubMed ID: 9188591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
    Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
    J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
    Whiteway A; Deru W; Prentice HG; Anderson R
    J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
    Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
    Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production.
    Li C; Samulski RJ
    Virology; 2005 Apr; 335(1):10-21. PubMed ID: 15823602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-amplification system for recombinant adeno-associated virus production.
    Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
    Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors.
    Gonçalves MA; Pau MG; de Vries AA; Valerio D
    Virology; 2001 Sep; 288(2):236-46. PubMed ID: 11601895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis.
    Philpott NJ; Giraud-Wali C; Dupuis C; Gomos J; Hamilton H; Berns KI; Falck-Pedersen E
    J Virol; 2002 Jun; 76(11):5411-21. PubMed ID: 11991970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids.
    Cao L; Liu Y; During MJ; Xiao W
    J Virol; 2000 Dec; 74(24):11456-63. PubMed ID: 11090141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.
    Xiao X; Li J; Samulski RJ
    J Virol; 1998 Mar; 72(3):2224-32. PubMed ID: 9499080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid.
    Smith RH; Afione SA; Kotin RM
    Biotechniques; 2002 Jul; 33(1):204-6, 208, 210-1. PubMed ID: 12139247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.
    Mietzsch M; Eddington C; Jose A; Hsi J; Chipman P; Henley T; Choudhry M; McKenna R; Agbandje-McKenna M
    J Virol; 2021 Sep; 95(19):e0077321. PubMed ID: 34287038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.